Your browser doesn't support javascript.
loading
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials.
Li, Mengnan; Zhang, Jian; Yang, Guimei; Zhang, Jiaxin; Han, Minmin; Zhang, Yi; Liu, Yunfeng.
Affiliation
  • Li M; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhang J; First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
  • Yang G; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhang J; First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
  • Han M; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhang Y; First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
  • Liu Y; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
Eur J Clin Pharmacol ; 79(6): 859-871, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37097298

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Eur J Clin Pharmacol Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Eur J Clin Pharmacol Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany